TEQWX
Price
$40.23
Change
-$0.10 (-0.25%)
Updated
Sep 20 closing price
VITSX
Price
$136.99
Change
-$0.34 (-0.25%)
Updated
Sep 20 closing price
Ad is loading...

TEQWX vs VITSX

Header iconTEQWX vs VITSX Comparison
Open Charts TEQWX vs VITSXBanner chart's image
Nuveen Equity Index W
Price$40.23
Change-$0.10 (-0.25%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Market Idx I
Price$136.99
Change-$0.34 (-0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TEQWX vs VITSX Comparison Chart
Loading...
VS
TEQWX vs. VITSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQWX is a Buy and VITSX is a Buy.

FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.72T vs. TEQWX (48B). TEQWX (1.37) and VITSX (1.36) have matching dividends . TEQWX was incepted earlier than VITSX: TEQWX (6 years) vs VITSX (27 years). TEQWX is a more actively managed with annual turnover of: 7.00 vs. VITSX (2.00). TEQWX has a lower initial minimum investment than VITSX: TEQWX (0) vs VITSX (5000000). TEQWX annual gain was more profitable for investors over the last year : 27.63 vs. VITSX (25.89). TEQWX return over 5 years is better than : 91.89 vs. VITSX (82.97).
TEQWXVITSXTEQWX / VITSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years27 years-
Gain YTD17.69616.918105%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets48B1.72T3%
Annual Yield % from dividends1.371.36101%
Returns for 1 year27.6325.89107%
Returns for 3 years24.1421.34113%
Returns for 5 years91.8982.97111%
Returns for 10 yearsN/A179.72-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CENT38.330.56
+1.48%
Central Garden & Pet Company
HFWA22.070.07
+0.32%
Heritage Financial Corp
SAMG16.64-0.03
-0.18%
Silvercrest Asset Management Group
JKHY174.21-1.48
-0.84%
Jack Henry & Associates
COEP0.18N/A
-2.50%
Coeptis Therapeutics Holdings